clinical trial finder

March 11, 2026

•

7 mins read

TrialX Updates: Leadership Insights, Patients as Partners 2026, Global Patient Recruitment and More…

As we return from an energizing week at SCOPE 2026 in Orlando, one thing is clear: the industry conversation has evolved. The focus has…

367

7 mins read

February 27, 2026

•

6 mins read

Rare Disease Awareness: Finding Tuberous Sclerosis Complex (TSC) Clinical Trials Through a Guided Search Experience

Rare Disease Day is observed every year on the last day of February. In the United States, a disease is considered rare (or orphan)…

317

6 mins read

February 13, 2026

•

7 mins read

TrialX at SCOPE 2026: Simplifying Patient Recruitment, Spotlighting Clinical Research Heroes — Coffee, Conversations & Key Insights

Team TrialX at SCOPE 2026: Sharib Khan (Co-founder & CEO), Wes Martz (Senior Director of Client Services), Beth Dickson (VP, Business Development), and Brandon…

294

7 mins read

February 12, 2026

•

6 mins read

SCOPE 2026, Simplified Patient Recruitment Management, AI Powered Clinical Trial Finders and More…

The 17th Annual SCOPE Summit once again brought together leaders across clinical operations, digital health, patient engagement, and data innovation to shape the future…

282

6 mins read

December 8, 2025

•

5 mins read

TrialX is Powering Global Studies with Multilingual Engagement, AI-Driven Trial Discovery & Remote Data Collection – on Earth and in Space

🦃 This holiday season, we’re especially grateful for partnerships that bring hope to patients and families. We are honored to power the AI-based clinical…

307

5 mins read

October 13, 2025

•

14 mins read

Leadership Spotlight: A Conversation with Lisa La Luna – Reflections on Diversity, Art, and the Future of Clinical Research

Throwback to October 13th! We were honored to power the Clinical Trial Finder for the groundbreaking Reflections initiative, a program transforming how communities engage…

299

14 mins read

October 9, 2025

•

4 mins read

From Breakthrough Status to Standard of Care: TAR-200’s Potential in Bladder Cancer Treatment

Can a pretzel-shaped device rewrite the story of bladder cancer? In September 2025, the U.S. Food and Drug Administration (FDA) approved Inlexzo™ (formerly TAR-200),…

244

4 mins read

September 17, 2025

•

3 mins read

AI-assisted ALS Clinical Trial Finder: Helping Patients and Caregivers Explore Latest Research Opportunities

ALS, or amyotrophic lateral sclerosis, is a progressive neurodegenerative disease that affects nerve cells controlling voluntary muscle movement. Each year, more than 5,000 people…

260

3 mins read